AstraZeneca CEO Pascal Soriot Updates On Chinese Compliance Probe And Lung Cancer Drug Trial Results
Recently, Chinese authorities detained some current and former employees of AstraZeneca Plc (NASDAQ:AZN) as part of a broader investigation into alleged illegal activities in the pharmaceutical sector ...
Monday - Friday, 6:00 - 7:00 PM ET In a Tuesday interview with CNBC's Jim Cramer, AstraZeneca CEO Pascal Soriot explained why the drugmaker believes it can almost double revenue by the end of the ...
(Alliance News) - AstraZeneca PLC could be forced to withhold new medicines from the UK and Europe unless governments pay more for innovative drugs, Chief Executive Officer Pascal Soriot told the ...
Monday - Friday, 08:00 - 11:00 CET | 14:00 - 17:00 HK/SG Pascal Soriot, CEO of British pharmaceutical giant AstraZeneca, discusses the company's $2.5 billion investment in a new China research and ...
AstraZeneca CEO Pascal Soriot joins CNBC’s Angelica Peebles to discuss the most promising drugs in AstraZeneca’s pipeline. He ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results